Ignite Creation Date:
2024-05-06 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03136653
Status:
COMPLETED
Last Update Posted:
2021-08-25
First Post:
2017-04-18
Brief Title:
A Phase 2 Trial of MP0250 Plus Bortezomib Dexamethasone in Patients With Multiple Myeloma
Sponsor:
Molecular Partners AG
Organization:
Molecular Partners AG
Organization Data
Organization:
Molecular Partners AG
Class:
INDUSTRY
Study ID:
MP0250-CP201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Molecular Partners AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None